68
Ascentage
6855.HK·HKEXSuzhou CNFounded 2010500 employees
Small CapbiotechPublicOncologyHematology
Platform: BCL-2/IAP
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (6855.HK)
Loading 6855.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pemifotisoran | 685-4368 | Phase 1/2 | 1 | CDK4/6 | CeliacMeso | ||
| Surainavolisib | 685-2378 | NDA/BLA | 2 | MALT1 | BCC |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Ascentage trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)